Syndax Pharmaceuticals (SNDX) Current Leases (2019 - 2026)
Syndax Pharmaceuticals (SNDX) recorded quarterly Current Leases of $487000.0 in Q1 2026, up 3.62% quarter-over-quarter from $470000.0 in Q4 2025, and up 29.18% on a YoY basis from $377000.0 in Q1 2025.
Syndax Pharmaceuticals (SNDX) Current Leases (2019 - 2026) Analysis & Trends
Syndax Pharmaceuticals' Current Leases history runs 8 years deep, the most recent figure standing at $487000.0 for Q1 2026.
- In Q1 2026, Current Leases rose 29.18% year-over-year to $487000.0; the TTM figure through Mar 2026 stood at $487000.0 (up 29.18% YoY), while the FY2025 annual figure was $470000.0, changed 0.21% from the prior year.
- Current Leases was $487000.0 for Q1 2026 at Syndax Pharmaceuticals, up from $470000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $1.0 million in Q1 2024 to a low of $299000.0 in Q2 2022.
- Historically, Current Leases has averaged $607000.0 across 5 years, with a median of $471000.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: Current Leases jumped 220.07% in 2023, then tumbled 64.93% in 2025.
- A 5-year view of Current Leases shows it stood at $434000.0 in 2022, then surged by 138.48% to $1.0 million in 2023, then slumped by 54.49% to $471000.0 in 2024, then fell by 0.21% to $470000.0 in 2025, then gained by 3.62% to $487000.0 in 2026.
- The last three Current Leases figures came in at $487000.0 (Q1 2026), $470000.0 (Q4 2025), and $329000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Syndax Pharmaceuticals | 1.69 Bn | 1.34 Bn | 53.02 Mn | 487,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 487,000.00 |
| Dec 31, 2025 | 470,000.00 |
| Sep 30, 2025 | 329,000.00 |
| Jun 30, 2025 | 344,000.00 |
| Mar 31, 2025 | 377,000.00 |
| Dec 31, 2024 | 471,000.00 |
| Sep 30, 2024 | 842,000.00 |
| Jun 30, 2024 | 981,000.00 |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 1.04 Mn |
| Sep 30, 2023 | 995,000.00 |
| Jun 30, 2023 | 957,000.00 |
| Mar 31, 2023 | 454,000.00 |
| Dec 31, 2022 | 434,000.00 |
| Sep 30, 2022 | 471,000.00 |
| Jun 30, 2022 | 299,000.00 |
| Mar 31, 2022 | 331,000.00 |
| Dec 31, 2021 | 361,000.00 |
| Sep 30, 2021 | 369,000.00 |
| Jun 30, 2021 | 397,000.00 |